NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Emergo Therapeutics logo
Moise Khayrallah, Ph.D., is a serial entrepreneur with a Midas touch. His latest startup, Durham-based Emergo Therapeutics, could be another golden opportunity after raising $12 million in venture capital this spring, mostly from North Carolina investors.
Humacyte logo
Morrisville-based Humacyte, developer of a bioengineered blood vessel, has formed a global partnership with Fresenius Medical Care, the world's largest provider of dialysis products and services, and will receive a $150 million equity investment as part of the deal.
Chimerix logo
Chimerix, a Durham-based biopharmaceutical company that’s developing novel antiviral medicines for unmet medical needs, has received Orphan Drug Designation from the U.S. Food and Drug Administration for brincidofovir, its smallpox treatment.
grifols logo
The United States Green Building Council has awarded Grifols’ newly built administration building the Leadership in Energy and Environmental Design (LEED) Silver certification -- the second of the company’s buildings on its Johnston County campus to receive LEED certification.
NC Pharmaceutical Services Network logo
Pitt County Development Commission and partner counties and organizations are packaging an“Active Site” theme and taking it on the road, to make sure the region is on the radar of any pharmaceutical company planning an expansion or a new manufacturing facility.
TyraTech logo
Morrisville-based TyraTech is beginning to make headway in the $10 billion global market for insect and parasite controls in livestock and companion animals.
Bondurant Sculpture
Stuart Bondurant's pioneering contribution to the state’s global life science leadership, as a co-founder of the North Carolina Biotechnology Center, is honored for all to see by a distinctive two-piece sculpture in the Center’s welcoming garden area.
Precision Biosciences logo
Precision BioSciences, a Durham-based genome editing company, has created a new name and brand identity for its food and agriculture business: Elo Life Systems.
World Environment Day

World Environment Day has helped raise awareness of environmental concerns such as: depletion of the ozone layer, toxic chemicals, desertification and global warming. Since it began in 1974, it has grown to become a global platform for public outreach that is widely celebrated in over 100 countries. 

North Carolina has previously celebrated the event by cleaning some public areas as part of the Adopt-A-Highway program. North Carolina is also a coastal state with a wealth of natural resources. Keeping plastics out of the ocean is also a big challenge in the state. 

BioGENEius Challenge
Sumani Nunna, a senior at the North Carolina School of Science and Mathematics in Durham, was one of the 15 finalists for the International BioGENEius Challenge, a major science competition for high school students.
Award photo
Three North Carolina life science companies and four universities were recently recognized for creating employee-friendly workplaces.
Forsyth Tech logo
Forsyth Technical Community College in Winston-Salem has won a $579,961 grant from the National Science Foundation (NSF) to define the workforce skills technicians will need for manufacturing jobs at the intersection of biomedical devices and tissue engineering.
bluebird bio logo
bluebird bio, a gene therapy company with operations in Durham, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for Lenti-D, its potential treatment for a rare and life-threatening neurological disorder in boys.
AveXis logo
AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs. 
Dova logo
Dova Pharmaceuticals of Durham has received approval from the U.S. Food and Drug Administration for its first commercial drug, a tablet for treating thrombocytopenia, or low blood platelet counts, which can cause dangerous bleeding.